2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
7
Stomach Neoplasms
2
Neoplasms
2
Warts
1
Uterine Cervical Neoplasms
1
Stomatitis
1
Solitary Pulmonary Nodule
1
Shock, Septic
1
Pain, Postoperative
1
Neoplasm Metastasis
1
Multiple Pulmonary Nodules
1
Melanoma
1
Lymphedema
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Emergence Delirium
1
Disease
1
Colorectal Neoplasms
1
Interventions
Indocyanine Green
7
Lymph Node Excision
6
Surgical Procedures, Operative
5
Radiotherapy, Intensity-Modulated
4
Radiotherapy
4
Radiosurgery
4
Magnetic Resonance Spectroscopy
4
Cisplatin
4
Specimen Handling
3
gadofosveset trisodium
2
Technetium
2
TP protocol
2
Sentinel Lymph Node Biopsy
2
Radiation Dose Hypofractionation
2
Nivolumab
2
Ipilimumab
2
Electroporation
2
Conversion to Open Surgery
2
Control Groups
2
Chemotherapy, Adjuvant
2
Chemoradiotherapy
2
Artificial Intelligence
2
tislelizumab
1
sarcolipin
1
radium Ra 223 dichloride
1
peposertib
1
pembrolizumab
1
lncRNA LNMAT1, human
1
gewf solution
1
fluoroazomycin arabinoside
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphatic Metastasis
×
Methylene Blue
×
Clear all
NCT04842968
2024-12-02
MB
St. Borbala Hospital
Phase NA
Completed
200 enrolled